Cerenome, Inc. (CNSY)
0.6875
+0.12
(+20.66%)
USD |
NASDAQ |
Nov 10, 16:00
0.66
-0.03
(-4.00%)
After-Hours: 20:00
Cerenome Cash from Operations (Annual) : -20.78M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -20.78M |
| December 31, 2024 | -10.55M |
| December 31, 2023 | -12.85M |
| December 31, 2022 | -12.97M |
| December 31, 2021 | -10.28M |
| December 31, 2020 | -8.434M |
| December 31, 2019 | -5.906M |
| December 31, 2018 | -11.98M |
| December 31, 2017 | -18.13M |
| December 31, 2016 | -19.53M |
| December 31, 2015 | -20.47M |
| December 31, 2014 | -30.33M |
| December 31, 2013 | -34.56M |
| December 31, 2012 | -32.19M |
| Date | Value |
|---|---|
| December 31, 2011 | -35.32M |
| December 31, 2010 | -23.57M |
| December 31, 2009 | -23.81M |
| December 31, 2008 | -33.39M |
| December 31, 2007 | -30.00M |
| December 31, 2006 | -16.48M |
| December 31, 2005 | -1.101M |
| December 31, 2004 | -12.57M |
| December 31, 2003 | -7.245M |
| December 31, 2002 | -6.886M |
| December 31, 2001 | -8.322M |
| December 31, 2000 | -2.982M |
| December 31, 1999 | -5.107M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Ernexa Therapeutics, Inc. | -7.017M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |